Category: Covid-19
-
Communicable disease threats report, 11-17 June 2023, week 24
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 11-17 June 2023 and includes updates on COVID-19, West Nile virus, chikungunya and dengue, avian influenza, measles, diphtheria, cholera, echovirus, and information on the Hajj .
-
Questions and answers on COVID-19
Find more information on questions related to COVID-19 on infection, symptoms, guidelines, the situation, in the EU, vaccines, travel, and children.
-
Communicable disease threats report, 5-11 June 2023, week 23
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5-11 June 2023 and includes updates on Middle East respiratory syndrome coronavirus (MERS-CoV), COVID-19, Mpox, Marburg virus disease and West Nile virus.
-
ECDC-EMA statement on updating COVID-19 vaccines composition for new SARS-CoV-2 virus variants
ECDC and EMA have issued a joint statement on adapted COVID-19 vaccines and considerations for their use during the upcoming autumn 2023 vaccination campaigns.
-
Communicable disease threats report, 28 May-3 June 2023, week 22
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 May – 3 June 2023 and includes updates on COVID-19, West Nile virus, Legionnaires’ disease, avian influenza, Marburg virus disease, cholera, and fungal meningitis.
-
The pathogen SARS-COV-2
COVID-19 disease is caused by a virus of the coronavirus family, SARS-CoV-2, in the order of nidovirales.
-
Surveillance of COVID-19
Well-designed, representative sentinel surveillance systems in primary and secondary care remain the core surveillance method for acute viral respiratory infections.
-
Case definition for COVID-19
COVID-19 is a disease under surveillance in the European Union (EU) and must be reported by all Member States.
-
Clinical features and sequelae – COVID-19
Symptoms may vary, both in frequency and severity, depending on the SARS-CoV-2 variant causing the disease episode.